HUANG MICHAEL F. (Sr. VP of Clinical Development) received a stock award from SOLENO THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/23/2026ACC: 0002019992-26-000001
Officer· Sr. VP of Clinical Development
Since Apr 2024
+22.30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
22.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.40K
Price / share
—
Trade value
—
% of position
28.9%
1/21/2026
36.01K→46.41K
Total
Net shares
+10.40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | A · Award | +10.40K | — | — | 28.9% | 36.01K | 46.41K |
| Total | +10.40K | $0.00 | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
11.90K shares
Shares
+11.90K
Strike price
43.65
Held after
11.90K
Exercisable
—
1/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock11.90K shares | 1/21/2026 | A · Award | +11.90K | 43.65 | — | 11.90K |